Article
Genetics, epigenetics and redox homeostasis in rhabdomyosarcoma: Emerging targets and therapeutics
27 Jan 2019
Abstract excerpt
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma accounting for 5-8% of malignant tumours in children and adolescents. Children with high risk disease have poor prognosis. Anti-RMS therapies include surgery, radiation and combination chemotherapy. While these strategies improved survival rates, they have plateaued since 1990s as drugs that target differentiation and self-renewal of tumours cells have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
